Urological Devices | Market Insights | Europe (Supplemental) | 2024
Driven by the increasing prevalence of kidney diseases, aging population, product innovation, and patient awareness of urological treatments in this region, the European urological device market will continue to expand through 2032, despite the short-term negative impact of the COVID-19 pandemic. Furthermore, favorable demographic trends, an increasing prevalence of obesity, adoption of premium devices, and the growing availability of less invasive treatment options will support urological procedure volume growth. Moreover, the rising use of minimally invasive laser treatments in Europe, where these techniques have been underpenetrated, will result in increased adoption of associated devices.
This Medtech 360 Report provides high-level market metrics for urological devices in Europe, including country-level data for major countries and aggregate data for the rest of the Europe from 2019 through 2032.
